RespireRx Pharmaceuticals Inc (fka RSPI)

[gershfinance]

I can only imagine this is good, if not neutral news. That things remain on track is certainly a positive. A question for the board....would COrtex need to state as a material event that some of the histopathology studies had negative findings if they did? Or oculd the info be all negative and still submitted to the FDA with no hope fo the data allowing the hold to be released?

Thanks in advance.